Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504)

PURPOSE: Inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase have demonstrated modest anticancer activity in advanced bronchioloalveolar carcinoma (BAC). We conducted a phase II study to evaluate cetuximab for the treatment of advanced BAC. PATIENTS AND METHODS: Patients with a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ramalingam, Suresh S., Lee, Ju-Whei, Belani, Chandra P., Aisner, Seena C., Kolesar, Jill, Howe, Craig, Velasco, Mario R., Schiller, Joan H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2011
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107763/
https://ncbi.nlm.nih.gov/pubmed/21422434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.4094
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi